Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA.
Psychopharmacology (Berl). 2018 Jan;235(1):47-58. doi: 10.1007/s00213-017-4739-x. Epub 2017 Sep 21.
Benztropine (BZT) analogs and other atypical dopamine uptake inhibitors selectively decrease cocaine self-administration at doses that do not affect responding maintained by other reinforcers. Those effects were further characterized in the current study using a behavioral economic assessment of how response requirement (price) affects reinforcers obtained (consumption) in rats.
Two groups of rats were trained to press levers with food (45-mg pellet) or cocaine (0.32 mg/kg/injection) reinforcement under fixed-ratio (FR) 5-response schedules. In selected sessions, the FR requirement was increased (5-80) during successive 20-min components to determine demand curves, which plot consumption against price. An exponential function was fitted to the data to derive the consumption at zero price (Q ) and the rate of decrease in consumption (essential value, EV) with increased price. The BZT analogs, AHN1-055, AHN2-005, JHW007 (3.2-10 or 17.8 mg/kg, each), vehicle, or comparison drugs (methylphenidate, ketamine), were administered i.p. before selected demand-curve determinations.
Consumption of cocaine or food decreased with increased FR requirement. Each drug shifted the demand curve rightward at the lowest doses and leftward/downward at higher doses. The effects on EV and Q were greater for cocaine than for food-reinforced responding. Additionally, the effects of the BZT analogs on EV and Q were greater than those obtained with a standard dopamine transport inhibitor, methylphenidate, and the NMDA antagonist, ketamine (1.0-10.0 mg/kg, each). With these latter drugs, the demand-curve parameters were affected similarly with cocaine and food-maintained responding.
The current findings, obtained using a behavioral economic assessment, suggest that BZT analogs selectively decrease the reinforcing effectiveness of cocaine.
苯扎托品(BZT)类似物和其他非典型多巴胺摄取抑制剂在不影响其他强化物维持的反应的剂量下选择性地降低可卡因的自我给药。在当前的研究中,使用一种行为经济学评估来进一步描述这些效果,该评估评估了反应要求(价格)如何影响大鼠获得的强化物(消耗)。
两组大鼠接受训练,使用食物(45 毫克丸)或可卡因(0.32 毫克/千克/注射)强化物,根据固定比率(FR)5 反应时间表进行按压杠杆。在选定的会议中,在连续的 20 分钟组成部分中增加 FR 要求(5-80),以确定需求曲线,该曲线绘制消耗与价格的关系。将指数函数拟合到数据中,以得出零价格(Q)的消耗和随着价格增加消耗的减少率(基本值,EV)。BZT 类似物 AHN1-055、AHN2-005、JHW007(3.2-10 或 17.8 毫克/千克,每种)、载体或比较药物(哌醋甲酯、氯胺酮)在选定的需求曲线测定之前通过腹腔内给药。
可卡因或食物的消耗随着 FR 要求的增加而减少。每种药物在最低剂量下将需求曲线向右移动,在较高剂量下向左/向下移动。与食物强化反应相比,药物对 EV 和 Q 的影响更大。此外,BZT 类似物对 EV 和 Q 的影响大于标准多巴胺转运抑制剂哌醋甲酯和 NMDA 拮抗剂氯胺酮(1.0-10.0 毫克/千克,每种)。对于这些后者药物,可卡因和食物维持的反应对需求曲线参数的影响相似。
使用行为经济学评估获得的当前发现表明,BZT 类似物选择性地降低可卡因的强化效力。